Medicare could save millions of dollars every year by changing the way they package Alzheimer's medication.

A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions ...

Making a 75-milligram vial available alongside the two current options of 200 milligrams and 500 milligrams could save ...

Current vial sizes may result in 5.8% of the Alzheimer's disease drug being thrown away, representing $1,619 in wasted ...

A recent study suggests that a drug approved for the treatment of seizures may also help treat Alzheimer's in people who do ...

On Monday, Eli Lilly And Co (NYSE:LLY) announced plans to boost its presence in the U.K., following a collaboration with the ...

Sage Therapeutics said on Tuesday it would stop developing its experimental drug, dalzanemdor, for Alzheimer's disease after ...

Australia's Therapeutic Goods Administration (TGA) has said it won't approve Eisai and Biogen's Alzheimer's disease therapy ...

Medicare could save up to 74% of the money lost from discarded Alzheimer's drug lecanemab by the simple introduction of a new ...

A much-anticipated drug that holds the promise of delaying symptoms of Alzheimer’s disease will not be available in Australia ...

Preclinical research in fruit flies and cell cultures suggests that a dual-targeting drug could help prevent the accumulation ...

Annovis has limited cash reserves and faces challenges in financing further trials, making the future of Buntanetap uncertain ...